Press Releases

Press Releases

November 10, 2020
Establishment Labs to Participate in Two Upcoming Investment Conferences
SANTA BARBARA, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its participation in two investment conferences this month.
November 9, 2020
Establishment Labs Reports Third Quarter 2020 Financial Results
SANTA BARBARA, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the third quarter ended September
October 21, 2020
Establishment Labs Celebrates 10 Years of Motiva Safety Data
Findings Show Less Than 1% Device Related Complications Nearly 1.3 Million Implants Placed Worldwide SANTA BARBARA, Calif., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics
October 21, 2020
Establishment Labs Reports Preliminary Third Quarter Revenue and Cash Balance
$22 million to $23 million 3 rd Quarter Preliminary Revenue C ash B alance at September 30, 2020 an E stimated $81.0 million Company to Announce Full 3 rd Quarter Results on November 9 SANTA BARBARA, Calif., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc.
October 7, 2020
Establishment Labs to Celebrate 10 Years of Motiva Safety Data at Plastic Surgeon Virtual Symposium
Event to Feature Members of Company’s Medical and Scientific Advisory Boards and U.S. IDE Medical Director SANTA BARBARA, Calif., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast
September 25, 2020
Establishment Labs Finalizes Distribution Agreement with Puregraft LLC
SANTA BARBARA, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has finalized an amendment to its distribution
September 21, 2020
Establishment Labs Announces Independent Publication Detailing New Advancements in Hybrid Breast Reconstruction Technique Using Motiva Ergonomix Implants
SANTA BARBARA, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced today that a recently published independent study concluded that
September 2, 2020
ESTA Announces Participation in the Wells Fargo Virtual Healthcare Conference
NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial
August 6, 2020
Establishment Labs Reports Second Quarter 2020 Financial Results
NEW YORK, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the second quarter ended June 30, 2020.
August 6, 2020
Establishment Labs Announces Transition to a Direct Sales Force in Italy
NEW YORK, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has entered into a definitive agreement with its Italian distributor
Displaying 1 - 10 of 25